Henry Schein (Nasdaq: HSIC) announced today that it appointed Scott Serota as a member of its board of directors.
Melville, N.Y.-based Henry Schein said in a news release that Serota will serve until the 2022 annual meeting of stockholders in May, at which point he is expected to stand for re-election to the board by a vote of the company’s stockholders.
In addition to his appointment to the board, Serota was appointed as a member of the board’s strategic advisory committee. Barry Alperin is set to retire from the board in May as well.
“Barry was instrumental in helping to guide Henry Schein through a period of accelerated growth, beginning shortly after our initial public offering in 1995,” Henry Schein Chairman & CEO Stanley M. Bergman said in the release. “He contributed significantly to our success, serving the company with distinction and providing counsel on matters such as strategic planning, governance, and executive compensation. On behalf of my colleagues, my fellow directors, and our shareholders, I extend our heartfelt thanks to Barry for his contributions to Team Schein.”
Serota joins Henry Schein having previously served as President & CEO of Blue Cross Blue Shield Association. He stepped down from Blue Cross Blue Shield in January 2021 after a 21-year tenure.
He also served on the Policy Committee of the White House Conference on Aging under President George W. Bush and as a charter member of the American Health Information Community by appointment of Bush.
“We are extremely fortunate to have Scott join our board,” Bergman said. “He has a deep understanding of the challenges facing Americans regarding access to care and the social determinants of health, along with considerable expertise in using data analytics to address health issues. We look forward to the contribution Scott will make to advance the strategic goals of the company.”